Search
Search Results
-
Aotearoa New Zealand health leader’s opinions on the implementation of a facility-based rehabilitation initiative for older people as an alternative to inpatient rehabilitation in an acute hospital setting
ObjectivesThis study aims to explore the opinions of key health leaders in Aotearoa New Zealand (Waikato Region) regarding a proposed facility-based...
-
How is Value Defined in Molecular Testing in Cancer? A Sco** Review
ObjectiveTo identify how value is defined in studies that focus on the value of molecular testing in cancer and the extent to which broadening the...
-
Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol
ObjectiveThe engagement of patients and family caregivers in value assessment is pivotal since they provide valuable contributions to assessment...
-
Preferences for the Societal Impacts of a Pandemic when it Transitions into an Endemic: A Discrete Choice Experiment
BackgroundThe stage of the pandemic significantly affects people’s preferences for (the societal impacts of) COVID-19 policies. No discrete choice...
-
The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol
BackgroundIn many countries, methods of economic evaluation and Health Technology Assessment are used to inform healthcare resource allocation...
-
The Role of Patient-Reported Outcomes to Measure Treatment Satisfaction in Drug Development
Treatment satisfaction is a person’s rating of his or her treatment experience, including processes and outcomes. It is directly related to treatment...
-
Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
BackgroundFor many decision makers in Health Technology Assessment the EQ-5D-5L is the standard measure of health-related quality of life (HRQL)....
-
A Multi-dimensional Framework of Valued Output for Primary Care in England
Improving efficiency and productivity are key aspects to ensure that general practices in England can meet the needs of a growing population with...
-
Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know
There is increasing interest in the use of cure modelling to inform health technology assessment (HTA) due to the development of new treatments that...
-
Discrete Choice Experiments to Elicit Patient Preferences for the Treatment of Major Depressive Disorder: A Systematic Review
BackgroundIndividual preferences for treatment options for major depressive disorder can impact therapeutic decision making, adherence, and...
-
Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review
Since 2017, immune checkpoint inhibitors (ICIs) have been available for the treatment of advanced hepatocellular carcinoma (HCC) or unresectable HCC,...
-
Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework
BackgroundThe majority of recent estimates on the direct medical cost attributable to hospital-onset infections (HOIs) has focused on device- or...
-
Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review
It is well accepted that medical devices (MDs) and procedures have several unique characteristics compared with pharmaceuticals, such as learning...
-
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France
IntroductionEsophageal and gastroesophageal junction cancer (EC/GEJC) is a poor prognosis disease with a high risk of recurrence even in patients...
-
Cost-benefit analysis of haemodialysis in patients with end-stage kidney disease in Abuja, Nigeria
BackgroundSignificant gaps in scholarship on the cost-benefit analysis of haemodialysis exist in low-middle-income countries, including Nigeria. The...
-
Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model
BackgroundPandemic influenza poses a recurring threat to public health. Antiviral drugs are vital in combating influenza pandemics. Baloxavir...
-
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia
IntroductionImmunocompromised host pneumonia (ICHP) is an important cause of morbidity and mortality, yet usual care (UC) diagnostic tests often fail...
-
Estimating an EQ-5D-Y-3L Value Set for Brazil
IntroductionThe EQ-5D-Y-3L is a generic measure of health-related quality of life in children and adolescents. Although the Brazilian-Portuguese...
